Beacon Pharmaceuticals PLC reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 2,147.54 million compared to BDT 1,844.41 million a year ago. Net loss was BDT 8.66 million compared to net income of BDT 228.91 million a year ago. Basic loss per share from continuing operations was BDT 0.04 compared to basic earnings per share from continuing operations of BDT 0.99 a year ago.
For the nine months, sales was BDT 6,354.59 million compared to BDT 6,187.13 million a year ago. Net income was BDT 593.18 million compared to BDT 827.21 million a year ago. Basic earnings per share from continuing operations was BDT 2.57 compared to BDT 3.58 a year ago.